Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

318
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
318

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes and Characteristics Across Age Groups of Patients with Positive MT-sDNA Stool Tests: Data from the New Hampshire Colonoscopy Registry.

Digestive diseases and sciences·2026
Same author

Dollars Needed to Pay per Early-Detected Colorectal Cancer Case in Stool-Based Screening.

Annals of internal medicine·2026
Same author

A quantitative framework to assess the potential of earlier cancer detection to improve cancer survival.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

Optimizing Colonoscopy Capacity to Maximize Colorectal Cancer Outcomes.

Gastro hep advances·2026
Same author

Optimization of methylated DNA markers to rule out endometrial cancer in patients with abnormal uterine bleeding.

Gynecologic oncology·2026

Related Experiment Video

Updated: Jun 13, 2025

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

6.9K

Algorithm Development and Early Performance Evaluation of a Next-Generation Multitarget Stool DNA Screening Test for

Thomas F Imperiale1,2, Zubin D Gagrat2, Martin Krockenberger2

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.

Gastro Hep Advances
|September 16, 2024
PubMed
Summary
This summary is machine-generated.

A new multitarget stool DNA (mt-sDNA) test shows high sensitivity and specificity for colorectal cancer (CRC) screening. This noninvasive test uses novel biomarkers to improve upon existing CRC detection methods.

Keywords:
Algorithm ValidationColorectal CancerColorectal Cancer ScreeningStool Test

More Related Videos

Quantification of Colonic Stem Cell Mutations
07:53

Quantification of Colonic Stem Cell Mutations

Published on: September 25, 2015

6.6K
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

13.9K

Related Experiment Videos

Last Updated: Jun 13, 2025

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

6.9K
Quantification of Colonic Stem Cell Mutations
07:53

Quantification of Colonic Stem Cell Mutations

Published on: September 25, 2015

6.6K
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

13.9K

Area of Science:

  • Oncology
  • Gastroenterology
  • Molecular Diagnostics

Background:

  • The multitarget stool DNA (mt-sDNA) assay is a noninvasive screening method for average-risk colorectal cancer (CRC).
  • A next-generation mt-sDNA test was developed using a new biomarker panel to enhance specificity while maintaining or increasing sensitivity.

Purpose of the Study:

  • To establish an algorithm and cutoff for the next-generation mt-sDNA test.
  • To validate the performance of this next-generation test using archived samples from the DeeP-C study.

Main Methods:

  • Algorithm development involved 3011 samples, with cross-validation to ensure reliability.
  • Validation utilized archived samples from the DeeP-C study, including 57 CRC cases, 583 advanced precancerous lesions (APLs), and 7022 negative samples.
  • The next-generation test incorporated methylated DNA markers (CERKL4, LRRCC4, PPP2R2C, ZNFDC1) and fecal hemoglobin.

Main Results:

  • The next-generation mt-sDNA test achieved 93.0% sensitivity for CRC and 48.4% sensitivity for APLs.
  • Specificity was 88.5% for the absence of advanced neoplasia and 90.4% for non-neoplastic findings or negative colonoscopy.
  • Algorithm development and cross-validation confirmed the reliability and reproducibility of the test.

Conclusions:

  • The next-generation mt-sDNA test demonstrates promising performance for CRC screening based on archived samples.
  • Further prospective validation in the BLUE-C study is planned to fully assess its clinical utility.